Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 701,900 | 607,300 | 60,300 | 389,100 | 314,000 |
| Depreciation Amortization | 50,300 | 32,300 | 16,200 | 62,900 | 45,800 |
| Income taxes - deferred | -3,800 | 500 | 2,400 | -12,400 | 1,400 |
| Accounts receivable | -10,700 | -200 | 22,700 | 8,500 | 9,200 |
| Other Working Capital | 171,300 | 272,900 | 59,100 | 52,500 | 26,500 |
| Other Operating Activity | 20,100 | 4,100 | -21,800 | -27,900 | -35,500 |
| Operating Cash Flow | $929,100 | $916,900 | $138,900 | $472,700 | $361,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -699,200 | -562,500 | -105,400 | -298,200 | -71,700 |
| PPE Investments | -48,400 | -30,300 | -14,300 | -106,700 | -88,900 |
| Purchase Of Investment | N/A | N/A | -700 | -3,000 | -1,500 |
| Sale Of Investment | 1,000 | 1,300 | N/A | 300 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,100 | N/A |
| Other Investing Activity | 1,600 | 1,300 | 600 | -5,100 | -3,700 |
| Investing Cash Flow | $-745,000 | $-590,200 | $-119,800 | $-412,700 | $-165,800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 220,300 | 214,100 | 208,300 | 1,305,000 | 705,100 |
| Debt Repayment | -219,000 | -212,900 | -78,300 | -895,400 | -359,800 |
| Common Stock Issued | 71,300 | 32,900 | 14,200 | 45,500 | 36,900 |
| Common Stock Repurchased | -300,700 | -300,600 | -300,000 | -496,900 | -474,200 |
| Other Financing Activity | 29,200 | 18,900 | 12,000 | 76,700 | 46,400 |
| Financing Cash Flow | $-198,900 | $-247,600 | $-143,800 | $34,900 | $-45,600 |
| Exchange Rate Effect | -1,500 | -900 | 0 | 14,600 | 10,100 |
| Beginning Cash Position | 420,400 | 420,400 | 420,400 | 310,900 | 310,900 |
| End Cash Position | 404,100 | 498,600 | 295,700 | 420,400 | 471,000 |
| Net Cash Flow | $-16,300 | $78,200 | $-124,700 | $109,500 | $160,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 929,100 | 916,900 | 138,900 | 472,700 | 361,400 |
| Capital Expenditure | -48,400 | -30,300 | -14,300 | -109,000 | -88,900 |
| Free Cash Flow | 880,700 | 886,600 | 124,600 | 363,700 | 272,500 |